iCoreConnect Inc. (NASDAQ:ICCT – Get Free Report) was the target of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 479,200 shares, an increase of 168.0% from the March 31st total of 178,800 shares. Currently, 5.8% of the company’s shares are sold short. Based on an average trading volume of 406,900 shares, the days-to-cover ratio is presently 1.2 days.
Institutional Investors Weigh In On iCoreConnect
Several institutional investors and hedge funds have recently bought and sold shares of the business. Cowen AND Company LLC purchased a new stake in iCoreConnect in the 3rd quarter worth approximately $60,000. Sapient Capital LLC purchased a new position in shares of iCoreConnect in the 4th quarter valued at approximately $39,000. Finally, Destiny Wealth Partners LLC lifted its stake in shares of iCoreConnect by 45.6% in the 4th quarter. Destiny Wealth Partners LLC now owns 101,675 shares of the company’s stock valued at $132,000 after purchasing an additional 31,825 shares during the period. Hedge funds and other institutional investors own 13.42% of the company’s stock.
iCoreConnect Stock Performance
ICCT opened at $1.10 on Friday. The stock’s 50 day simple moving average is $1.29 and its 200 day simple moving average is $1.44. iCoreConnect has a 1 year low of $0.12 and a 1 year high of $20.70.
About iCoreConnect
iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.
Further Reading
- Five stocks we like better than iCoreConnect
- What is Short Interest? How to Use It
- MarketBeat Week in Review – 4/22 – 4/26
- How to Invest in Biotech Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for iCoreConnect Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCoreConnect and related companies with MarketBeat.com's FREE daily email newsletter.
